ArticleAllergy2025
Comparison of CD30L and OX40L Reveals CD30L as a Promising Therapeutic Target in Atopic Dermatitis.
Rinkesh K Gupta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleAllergy2025
Rinkesh K Gupta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.